Focal gray matter changes in schizophrenia across the course of the illness: A 5-year follow-up study

被引:247
|
作者
van Haren, Neeltje E. M.
Pol, Hilleke E. Hulshoff
Schnack, Hugo G.
Cahn, Wiepke
Mandl, Rene C. W.
Collins, D. Louis
Evans, Alan C.
Kahn, Rene S.
机构
[1] Univ Med Ctr Utrecht, Rudolf Magnus Inst Neurosci, Dept Psychiat, NL-3584 CX Utrecht, Netherlands
[2] McGill Univ, Montreal Neurol Inst, Montreal, PQ, Canada
关键词
schizophrenia; MRI; follow-up; voxel-based morphometry; frontal lobe; antipsychotic medication;
D O I
10.1038/sj.npp.1301347
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Recent volumetric magnetic resonance imaging ( MRI) studies have suggested brain volume changes in schizophrenia to be progressive in nature. Whether this is a global process or some brain areas are more affected than others is not known. In a 5-year longitudinal study, MRI whole brain scans were obtained from 96 patients with schizophrenia and 113 matched healthy comparison subjects. Changes over time in focal gray and white matter were measured with voxel-based morphometry throughout the brain. Over the 5-year interval, excessive decreases in gray matter density were found in patients in the left superior frontal area (Brodmann areas 9/10), left superior temporal gyrus (Brodmann area 42), right caudate nucleus, and right thalamus as compared to healthy individuals. Excessive gray matter density decrease in the superior frontal gray matter was related to increased number of hospitalizations, whereas a higher cumulative dose of clozapine and olanzapine during the scan interval was related to lesser decreases in this area. In conclusion, gray matter density loss occurs across the course of the illness in schizophrenia, predominantly in left frontal and temporal cortices. Moreover, the progression in left frontal density loss appears to be related to an increased number of psychotic episodes, with atypical antipsychotic medication attenuating these changes.
引用
收藏
页码:2057 / 2066
页数:10
相关论文
共 50 条
  • [21] Need assessment and quality of life in outpatients with schizophrenia: a 5-year follow-up study
    Foldemo, A
    Bogren, L
    SCANDINAVIAN JOURNAL OF CARING SCIENCES, 2002, 16 (04) : 393 - 398
  • [22] A 5-year follow-up study of brain cortical and subcortical abnormalities in a schizophrenia cohort
    Nesvag, Ragnar
    Bergmann, Orjan
    Rimol, Lars M.
    Lange, Elisabeth H.
    Haukvik, Unn K.
    Hartberg, Cecilie B.
    Fagerberg, Thomas
    Soderman, Erik
    Jonsson, Erik G.
    Agartz, Ingrid
    SCHIZOPHRENIA RESEARCH, 2012, 142 (1-3) : 209 - 216
  • [23] Living situation and social network in schizophrenia - A prospective 5-year follow-up study
    Salokangas, RKR
    NORDIC JOURNAL OF PSYCHIATRY, 1996, 50 (01) : 35 - 42
  • [24] Trajectories of subcortical volume change in schizophrenia: A 5-year follow-up
    van Haren, Neeltje E. M.
    Schnack, Hugo G.
    Koevoets, Martijn G. J. C.
    Cahn, Wiepke
    Pol, Hilleke E. Hulshoff
    Kahn, Rene S.
    SCHIZOPHRENIA RESEARCH, 2016, 173 (03) : 140 - 145
  • [25] EXERCISE ELECTROCARDIOGRAMS IN A 5-YEAR FOLLOW-UP STUDY
    ASTRAND, I
    ACTA MEDICA SCANDINAVICA, 1963, 173 (03): : 257 - +
  • [26] OVARIAN MESENCHYMOMAS - A 5-YEAR FOLLOW-UP STUDY
    DIDDLE, AW
    DEVEREUX, WP
    OBSTETRICS AND GYNECOLOGY, 1959, 13 (03): : 294 - 298
  • [27] A 5-year follow-up study of suicide attempts
    Fridell, EJ
    Ojehagen, A
    TraskmanBendz, L
    ACTA PSYCHIATRICA SCANDINAVICA, 1996, 93 (03) : 151 - 157
  • [28] 5-YEAR FOLLOW-UP STUDY OF CONDOM CASES
    NADKARNI, MW
    VIRKAR, KD
    JOURNAL OF FAMILY WELFARE, 1967, 14 (01): : 50 - 55
  • [29] Course of microalbuminuria in type 2 diabetic patients: a 5-year follow-up study
    Murussi, M.
    Campagnolo, N.
    Coester, A.
    Beck, M. O.
    Gross, J. L.
    Silveiro, S. P.
    DIABETOLOGIA, 2006, 49 : 641 - 642
  • [30] CHEMONUCLEOLYSIS - 5-YEAR FOLLOW-UP
    DAY, PL
    CLINICAL ORTHOPAEDICS AND RELATED RESEARCH, 1975, (109) : 214 - 214